Phosphodiesterase inhibitors: haemodynamic effects related to the treatment of cardiac failure
Hillis, W.S.; Been, M.
European Heart Journal 3 Suppl D: 97-101
1982
ISSN/ISBN: 0195-668X PMID: 6761131 Document Number: 184003
Document emailed within 1 workday
Related Documents
Sakimura, S.; Yoshino, J.; Izumi, K.; Jimi, N.; Sumiyoshi, R.; Mizuno, K. 2013: Comparison of the effects of phosphodiesterase IIi inhibitors, milrinone and olprinone, in infant corrective cardiac surgery MASUI. Japanese Journal of Anesthesiology 62(5): 583-588Pinaud, M.; Arnould, F.; Souron, R.; Nicolas, F. 1983: Influence of cardiac rhythm on the haemodynamic effects of fazadinium in patients with heart failure British Journal of Anaesthesia 55(6): 507-512
Pande, A.K.; Ambardekar, S.S.; Kumar, A.; Tulpule, A.T.; Goyal, B.K. 1985: Haemodynamic effects of intravenous isosorbide dinitrate in patients of cardiac failure following acute myocardial infarction Indian Heart Journal 37(6): 339-342
Sharpe, D.N.; Douglas, J.E.; Coxon, R.J.; Long, B. 1980: Low-dose captopril in chronic heart failure: acute haemodynamic effects and long-term treatment Lancet 2(8205): 1154-1157
Arbogast, R. 1993: Effects of phosphodiesterase inhibitors on diastolic function Archives des Maladies du Coeur et des Vaisseaux 86(Special Issue 2): 65-69
Barnette, M.S.; Manning, C.D.; Cieslinski, L.B.; Burman, M.; Christensen, S.B.; Torphy, T.J. 1995: The ability of phosphodiesterase IV inhibitors to suppress superoxide production in guinea pig eosinophils is correlated with inhibition of phosphodiesterase IV catalytic activity Journal of Pharmacology and Experimental Therapeutics 273(2): 674-679
Chen, H.-d.; Ye, X.-t.; Weng, Z.-l.; Li, C.-d. 2011: Effects and mechanisms of phosphodiesterase type 5 inhibitors on rats with overactive bladder Zhonghua Yi Xue Za Zhi 91(28): 2001-2005
Kramer, G.L.; Wells, J.N. 1979: Effects of phosphodiesterase inhibitors on cyclic nucleotide levels and relaxation of pig coronary arteries Molecular Pharmacology 16(3): 813-822
Howell, R.E.; Sickels, B.D.; Woeppel, S.L. 1993: Pulmonary antiallergic and bronchodilator effects of isozyme-selective phosphodiesterase inhibitors in guinea pigs Journal of Pharmacology and Experimental Therapeutics 264(2): 609-615
Tan, L.B.; Bryant, S.; Murray, R.G. 1988: Detrimental haemodynamic effects of cyclizine in heart failure Lancet 1(8585): 560-561
Pokar, H.; Brandt, L. 1983: Haemodynamic effects of atracurium in patients after cardiac surgery British Journal of Anaesthesia 55(Suppl 1): 139s
Souness, J.E.; Foster, M. 1998: Potential of phosphodiesterase type of IV inhibitors in the treatment of rheumatoid arthritis Idrugs: the Investigational Drugs Journal 1(5): 541-553
Simko, F.; Riecanský, I. 1996: ACE-inhibitors in the treatment of chronic heart failure: pathophysiologic principles of protective effects Bratislavske Lekarske Listy 97(10): 583-586
Cowley, A.J.; Wynne, R.D.; Stainer, K.; Fullwood, L.; Rowley, J.M.; Hampton, J.R. 1988: Flosequinan in heart failure: acute haemodynamic and longer term symptomatic effects Bmj 297(6642): 169-173
Jochem, J.; Zwirska-Korczala, K.; Gwóźdź, B.; Walichiewicz, P.; Jośko, J. 2003: Cardiac and regional haemodynamic effects of endothelin-1 in rats subjected to critical haemorrhagic hypotension Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 54(3): 383-396
Heikkilä, J.; Pellinen, T.J.; Blake, P.; McAllister, A.; Yardley, J. 1987: Increase of cardiac output by afterload reduction in patients with severe congestive heart failure using nitroglycerin discs. A double-blind placebo-controlled haemodynamic study Annals of Clinical Research 19(3): 203-207
Fitzpatrick, D.; Nicholls, M.G.; Ikram, H.; Espiner, E.A. 1983: Acute haemodynamic, hormonal and electrolyte effects and short-term clinical response to enalapril in heart failure Journal of Hypertension. Supplement: Official Journal of the International Society of Hypertension 1(1): 147-153
Kowalsky, M.; Grove, R.; Kranig, W.; Kluczka, A. 2001: Acute haemodynamic effects of AV-synchronous pacemaker stimulation in patients with congestive heart failure and left bundle branch block Przeglad Lekarski 58(5): 415-418
Campanari, J.C.; Zillioto, E.E.; Formícola, A.; Lunardi, W.; Chryssovergis, G.; Timoner, M.; Forti, N.; Netto, M.P.; Giannini, S.D. 1974: Clinical effects of beta-methyl-digoxin in the treatment of cardiac failure caused by myocardiopathies Amb: Revista da Associacao Medica Brasileira 20(6): 226-228
Weber, K.T.; Janicki, J.S.; Jain, M.C. 1986: Enoximone (MDL 17,043), a phosphodiesterase inhibitor, in the treatment of advanced, unstable chronic heart failure Journal of Heart Transplantation 5(2): 105-112